| Mouse models of thyroid cancer: A 2015 update LS Kirschner, Z Qamri, S Kari, A Ashtekar Molecular and Cellular Endocrinology 421, 18-27, 2016 | 33 | 2016 |
| Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy D Zhang, RM Reyes, E Osta, S Kari, HB Gupta, AS Padron, ... Cancer Medicine 10 (6), 2137-2152, 2021 | 32 | 2021 |
| PKA activates AMPK through LKB1 signaling in follicular thyroid cancer S Kari, VV Vasko, S Priya, LS Kirschner Frontiers in Endocrinology 10, 477317, 2019 | 29 | 2019 |
| Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice S Kari, JC Flynn, M Zulfiqar, DP Snower, BE Elliott, YM Kong Thyroid 23 (12), 1590-1599, 2013 | 19 | 2013 |
| Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours S Dada, SLS Ellis, C Wood, LL Nohara, C Dreier, NH Garcia, ... Frontiers in Immunology 13, 982082, 2023 | 6 | 2023 |
| 15Th international thyroid congress program and meeting abstracts RN Miguel, J Sanders, J Furmaniak, BR Smith, C Li, F Menconi Thyroid 25, 2015 | 2 | 2015 |
| Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1 … H Bai, AS Padron, Y Deng, YJ Liao, CJ Murray, C Ontiveros, SJ Kari, ... Journal for Immunotherapy of Cancer 11 (2), 2023 | 1 | 2023 |
| PHARMACOLOGIC TUMOR PD-L1 DEPLETION WITH CHLORAMBUCIL TREATS OVARIAN CANCER AND MELANOMAS IN A TUMOR PD-L1-DEPENDENT MANNER AND RENDERS alpha PD-L1-RESISTANT TUMORS alpha PD-L1 … H Bai, A Padron, Y Deng, A Kornepati, S Polusani, S Kari, C Murray, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 9, A261-A261, 2021 | 1 | 2021 |
| Tumor cell-intrinsic PD-L1 signals promote DNA damage responses that mediate resistance to Chk1 and PARP inhibitors in vivo AV Kornepati, D Zhang, AS Padron, JT Boyd, Y Deng, EG Osta, ... The Journal of Immunology 204 (1_Supplement), 241.33-241.33, 2020 | 1 | 2020 |
| Tumor-intrinsic PD-L1 reduces actin cytoskeleton polymerization to promote mTORC1 signals driving tumor stemness SC Kari, A Kancharla, HB Gupta, A Risinger, TJ Curiel The Journal of Immunology 202 (1_Supplement), 137.8-137.8, 2019 | 1 | 2019 |
| Cell-intrinsic programmed death ligand-1 (PD-L1) inhibits cytotoxic chemo, promotes DNA damage repair, and enhances ATM/ATR signaling following exposure to DNA damaging agents … AV Kornepati, D Zhang, HG Hambright, SC Kari, Y Deng, CA Clark, ... The Journal of Immunology 202 (1_Supplement), 195.17-195.17, 2019 | 1 | 2019 |
| Conclusive demonstration of iatrogenic Alzheimer’s disease transmission in a model of stem cell transplantation CSB Singh, KM Johns, S Kari, L Munro, A Mathews, F Fenninger, ... Stem Cell Reports 19 (4), 456-468, 2024 | | 2024 |
| A novel type-2 innate lymphoid cell-based immunotherapy for cancer I Saranchova, CW Xia, S Besoiu, PL Finkel, SLS Ellis, S Kari, L Munro, ... Frontiers in Immunology 15, 1317522, 2024 | | 2024 |
| An ATP-Binding Cassette Transporter Gene Links Innate and Adaptive Immune Responses S Wilcox, H Arora, KB Choi, S Kari, L Munro, CG Pfeifer, WA Jefferies bioRxiv, 2023.12. 31.573785, 2024 | | 2024 |
| Outside-in signaling through the major histocompatibility complex class-I cytoplasmic tail modulates glutamate receptor expression in neurons BA Eyford, MJ Lazarczyk, KB Choi, M Varghese, H Arora, S Kari, L Munro, ... Scientific Reports 13 (1), 13079, 2023 | | 2023 |
| Cytoplasmic Signalling by Major Histocompatibility Class-I Proteins Modulates Synaptic Glutamate Receptors BA Eyford, MJ Lazarczyk, M Varghese, KB Choi, H Arora, L Munro, ... | | 2023 |
| A Binary RNA and DNA Self-Amplifying Platform for Next Generation Vaccines and Therapeutics WA Jefferies, KB Choi, P Ribeca, S Kari, J Young, E Hui, SY Qi, ... bioRxiv, 2022.12. 06.519322, 2022 | | 2022 |
| A Binary RNA and DNA Self-Amplifying Platform for Next Generation Vaccines and Therapeutics (preprint) W Jefferies, KB Choi, P Ribeca, S Kari, J Young, E Hui, SY Qi, ... | | 2022 |
| 242 Pharmacologic tumor PD-L1 depletion with chlorambucil treats ovarian cancer and melanomas in a tumor PD-L1-dependent manner and renders αPD-L1-resistant tumors αPD-L1-sensitive H Bai, Á Padrón, Y Deng, A Kornepati, S Polusani, K Suresh, C Murray, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A261-A261, 2021 | | 2021 |
| 298 Tumor cell-intrinsic mTORC1 signaling through raptor makes melanoma and ovarian cancer immunotherapy resistant by regulating interferon-gamma responsiveness and promoting … H Gupta, S Kari, E Salinas, H Bai, E Osta, A Kornepati, J Wang, X Zhang, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
